A peer-reviewed report of the work, funded by the National Institutes of Health, published online June 2 in Ophthalmology
The Tirzepatide Dose Escalation Schedule and Timeline After starting at 2.5 mg, most patients increase their weekly tirzepatide dose in 2.5 mg increments every four weeks, progressing toward therapeutic maintenance doses of 5 mg, 7.5 mg, 10 mg, or 15 mg
Misconception: heart rate effects mean you should use a lower dose Not necessarily
Treatment decisions often depend on: The best option is the one that aligns with a patients health profile and can be followed consistently over time
Conversely, on January 11, 2024, the Food and Drug Administration did not rule out a potential small risk and is conducting a meta-analysis of clinical trials and post-marketing data in the Sentinel System [181]